Laddar...
Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment
INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and irreversible lung disease. Licensed treatment options for IPF are pirfenidone and nintedanib. The aim of this study was to assess the impact of antifibrotic therapy in patients with IPF with preserved lung function based...
Sparad:
| I publikationen: | Adv Ther |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Healthcare
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854391/ https://ncbi.nlm.nih.gov/pubmed/33098554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01523-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|